Nucleotide inhibitors as precision medicine in breast cancer
Ended Project Grant Awarded Last action
- Award ID
- R41CA257002
- Recipient
-
Recombination Therapeutics LLC UEI JLYJMA2WFYE3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $399,757
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Pennsylvania, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $399,757 |
Quick answers
Who received award R41CA257002?
R41CA257002 was awarded to Recombination Therapeutics LLC by National Cancer Institute (National Institutes of Health) on September 18, 2020.
How much is award R41CA257002 worth?
$399,757 has been obligated on R41CA257002.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award